Early and late outcomes of patients treated with graft replacement of the inferior vena cava for malignant disease: A single-center experience over three decades
IVC resection and graft replacement for malignant disease are safe and durable, and provide excellent local control of the tumor, offering a chance for long-term survival in select patients.
Authors
- Taleen A. MacArthur (ORCID: https://orcid.org/0000-0001-6627-781X)
- Bernardo C. Mendes (ORCID: https://orcid.org/0000-0001-6881-0681)
- Mark Joseph Truty (ORCID: https://orcid.org/0000-0003-3776-527X)
- Fahad Shuja (ORCID: https://orcid.org/0009-0003-2274-1723)
- Todd E. Rasmussen (ORCID: https://orcid.org/0000-0003-1120-4116)
- Thomas C. Bower
- Péter Gloviczki (ORCID: https://orcid.org/0000-0002-9352-8044)
- David M. Nagorney (ORCID: https://orcid.org/0000-0003-4053-9476)
- Randall R. DeMartino (ORCID: https://orcid.org/0000-0003-2053-7553)
- Jill J. Colglazier (ORCID: https://orcid.org/0000-0002-6670-4719)
- Melinda S. Schaller
- Manju Kalra
- Kenneth J. Cherry
Institutions
- UCLA Medical Center (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- University of Virginia (US)
Publication Details
- Journal
- Journal of Vascular Surgery Venous and Lymphatic Disorders
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.jvsv.2025.102326
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00